Efficacy and safety of pegylated (40-kd) interferon α-2a compared with interferon α-2a in noncirrhotic patients with chronic hepatitis C

K. R. Reddy, T. L. Wright, P. J. Pockros, M. Shiffman, G. Everson, R. Reindollar, M. W. Fried, P. P. Purdum, D. Jensen, C. Smith, W. M. Lee, T. D. Boyer, A. Lin, S. Pedder, J. DePamphilis